Biblio

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

V

Kakehashi A, Kato A, Ishii N, Wei M, Morimura K, Fukushima S, Wanibuchi H. Valerian Inhibits Rat Hepatocarcinogenesis by Activating GABA(A) Receptor-Mediated Signaling. PLoS One. 2014;9(11):e113610.

Quan L-Q, Wang Y, Tang J-X, Zhou Y, Liao C-C, Liu D, Zhao X-D, Li R-T, Li H-M. Valeridoids G - Q, Eleven seco-Iridoids from Valeriana jatamansi and Their Bioactivites. Chem Biodivers. 2022:e202200609.

Toth K, Ying B, Tollefson AE, Spencer JF, Balakrishnan L, Sagartz JE, Buller RMark L, Wold WSM. Valganciclovir Inhibits Human Adenovirus Replication and Pathology in Permissive Immunosuppressed Female and Male Syrian Hamsters. Viruses. 2015;7(3):1409-1428.

Mullanfiroze K, Gupta S, Singhal T, Tulpule S, Sen S. Valgancyclovir-induced encephalopathy in a child after hematopoietic stem cell transplant. Pediatr Blood Cancer. 2019:e27718.

Qayed M, Kapoor U, Gillespie S, Westbrook A, Aguayo-Hiraldo P, A Ayuk F, Aziz M, Baez J, Choe H, DeFilipp Z, et al. A validated risk stratification that incorporates MAGIC biomarkers predicts long term outcomes in pediatric patients with acute GVHD. Transplant Cell Ther. 2024.

Ansil BR, George CElizabeth, Chandrasingh S, Viswanathan A, Thattai M, Raghu P, Devadiga S, Harikumar AGeetha, Harsha PKandi, Nair I, et al. Validating saliva as a biological sample for cost-effective, rapid and routine screening for SARS-CoV-2. Indian J Med Microbiol. 2023;45:100384.

Lim ABM, Roberts AW, Mason K, Bajel A, Szer J, Ritchie DS. Validating the Allogeneic Stem Cell Transplantation Disease Risk Index: Sample Size, Follow-up, and Local Data Are Important. Transplantation. 2014.

Bolden CT, Skibber MA, Olson SD, Rojas MZamorano, Milewicz S, Gill BS, Cox CS. Validation and characterization of a novel blood-brain barrier platform for investigating traumatic brain injury. Sci Rep. 2023;13(1):16150.

Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio ME, Maziarz RT, Antin JH, Soiffer RJ, Weisdorf DJ, et al. Validation and refinement of the disease risk index for allogeneic stem cell transplantation: a study from the CIBMTR. Blood. 2014.

Huntsman MCarrell, Kurashima CKehaulani, Marikawa Y. Validation of a mouse 3D gastruloid-based embryotoxicity assay in reference to the ICH S5(R3) guideline chemical exposure list. Reprod Toxicol. 2024:108558.

Rodríguez-Veiga R, Montesinos P, García E, Boluda B, Rojas R, Serrano J, Martínez-Cuadrón D, Martín C, Sanz J, Tabares S, et al. Validation of a multivariable prediction model for post-engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipients. Mycoses. 2019.

Steininger P, Korn K, Hackstein H, Strasser EF. Validation of a Parvovirus B19 NAT Assay for Screening of Umbilical Cord Blood for Allogenic Hematopoietic Stem Cell Donation. Transfus Med Hemother. 2024;51(1):48-51.

Agulnik A, Forbes PW, Stenquist N, Rodriguez-Galindo C, Kleinman M. Validation of a Pediatric Early Warning Score in Hospitalized Pediatric Oncology and Hematopoietic Stem Cell Transplant Patients. Pediatr Crit Care Med. 2016.

Ai D, Yin Y, Xia X, Yang S, Sun Y, Zhou J, Qin H, Xu X, Song J. Validation of a physiological type 2 diabetes model in human periodontal ligament stem cells. Oral Dis. 2023.

Sandner S, Merz E-M, van den Hurk K, van Kraaij M, Mikkelsen C, Ullum H, Clement M. Validation of a standardized donor health questionnaire across substances of human origin. Vox Sang. 2020.

Gill EL, Gill CM, McEvoy C. Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population. Ann Hematol. 2024.

Pinal-Fernandez I, Pak K, Casal-Dominguez M, Hosono Y, Mecoli C, Christopher-Stine L, Mammen AL. Validation of anti-Mi2 autoantibody testing by line blot. Autoimmun Rev. 2019:102425.

Qi S, Li B, Yang T, Liu Y, Cao S, He X, Zhang P, Li L, Xu C. Validation of Bmi1 as a Therapeutic Target of Hepatocellular Carcinoma in Mice. Int J Mol Sci. 2014;15(11):20004-20021.

Mohamed S-A, Viknaswaran NLee, Doran J, Sanz-Nogués C, Ahmed K, Howard L, Tubassam M, O'Brien T, Walsh SRedmond. Validation of ERICVA Risk Score as a Predictor of One Year Amputation-Free Survival of Patients with Critical Limb Ischemia. Ann Vasc Surg. 2021.

Bala M, Pratap K, Verma PKumar, Singh B, Padwad Y. Validation of ethnomedicinal potential of Tinospora cordifolia for anticancer and immunomodulatory activities and quantification of bioactive molecules by HPTLC. J Ethnopharmacol. 2015:JEPD1500646.

Cîmpean AMaria, Comşa Ş, Sturza A, Barb ACristina, Cosma AAlexandru, Fenesan MPasca, Ionescu C, Ile AMaria, Sarb S, Chis M. Validation of Human Bone Marrow-derived Mesenchymal Stem Cells and MCF-7 Breast Cancer Cells Co-culture Using a 3D Perfused Biomimetic Microfluidic Platform. Anticancer Res. 2024;44(4):1441-1453.

Mohanna A, Owaidah A, Albahrani A, Aldossary S, Almulhem N, Almohanna H. Validation of long-term handling and storage conditions for hematopoietic stem cell products for autologous transplants. J Med Life. 2023;16(4):515-519.

Kakodkar P, Zhao Y, Pan H, Wu F, Pearce T, Webster D, Elemary M, Sabry W, Kwan L, Pelzer L, et al. Validation of next-generation sequencing-based chimerism testing for accurate detection and monitoring of engraftment in hematopoietic stem cell transplantation. Front Genet. 2023;14:1282947.

Korell F, DeFilipp Z, Schreck N, Luft T. Validation of pre-conditioning EASIX for prediction of sepsis after allogeneic stem cell transplantation. Intensive Care Med. 2023.

Gaur N, Ortega F, Verkerk AO, Mengarelli I, Krogh-Madsen T, Christini DJ, Coronel R, Vigmond EJ. Validation of quantitative measure of repolarization reserve as a novel marker of drug induced proarrhythmia. J Mol Cell Cardiol. 2020.

Pages